California Supreme Court Upholds the State's Problematic Arrestee DNA Collection Law
By Jennifer Lynch,
Electronic Frontier Foundation
| 04. 02. 2018
In a disappointing and deeply divided opinion released today, the California Supreme Court upheld a state law law mandating DNA collection from arrestees. A lower court had held this law violated the privacy and search and seizure protections guaranteed under the California constitution. Today’s decision lets this flawed law stand.
The case, People v. Buza, involved a San Francisco man who challenged his conviction for refusing to provide a DNA sample after he was arrested. California law allows police to collect DNA from anyone arrested on suspicion of a felony—without a warrant or any finding by a judge that there was sufficient cause for the arrest. The state stores arrestees’ DNA samples indefinitely, and allows DNA profiles to be searched continuously by local, state, and federal law enforcement agencies.
EFF weighed in on the case in 2015, filing an amicus brief arguing the state’s constitution prohibits the collection of DNA from arrestees because of the severe impact DNA collection has on our right to privacy. Our DNA contains our entire genetic makeup—private and personal information that maps who we are, where we...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...
